Hisamitsu Pharmaceutical's Full-Year Profit Drops 12%

MT Newswires Live04-13 16:47

Hisamitsu Pharmaceutical's (TYO:4530) profit attributable to owners of the parent fell 12% to 19.2 billion yen for the fiscal year ended Feb. 28 from 21.8 billion yen a year earlier.

The pharmaceutical group's earnings per share declined to 268.22 yen from 295.15 yen a year ago, according to a Tokyo bourse filing on Monday.

Net sales rose 4.5% to over 163 billion yen from 156 billion yen in the prior year.

For the fiscal year ending Feb. 28, 2027, the company does not provide an earnings forecast due to its scheduled delisting on May 11.

Hisamitsu Pharmaceutical plans to pay no dividends for the current fiscal year, which is lower than the 90 yen per share paid in the year-ago period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2627433070?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-13 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2627433070","market":"fut","top_or_hot":-1,"title":"Hisamitsu Pharmaceutical's Full-Year Profit Drops 12%","media":"MT Newswires Live","content":"<html><body><p> Hisamitsu Pharmaceutical's (TYO:4530) profit attributable to owners of the parent fell 12% to 19.2 billion yen for the fiscal year ended Feb. 28 from 21.8 billion yen a year earlier.</p><p>The pharmaceutical group's earnings per share declined to 268.22 yen from 295.15 yen a year ago, according to a Tokyo bourse filing on Monday.</p><p>Net sales rose 4.5% to over 163 billion yen from 156 billion yen in the prior year.</p><p>For the fiscal year ending Feb. 28, 2027, the company does not provide an earnings forecast due to its scheduled delisting on May 11.</p><p>Hisamitsu Pharmaceutical plans to pay no dividends for the current fiscal year, which is lower than the 90 yen per share paid in the year-ago period.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hisamitsu Pharmaceutical's Full-Year Profit Drops 12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHisamitsu Pharmaceutical's Full-Year Profit Drops 12%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-13 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Hisamitsu Pharmaceutical's (TYO:4530) profit attributable to owners of the parent fell 12% to 19.2 billion yen for the fiscal year ended Feb. 28 from 21.8 billion yen a year earlier.</p><p>The pharmaceutical group's earnings per share declined to 268.22 yen from 295.15 yen a year ago, according to a Tokyo bourse filing on Monday.</p><p>Net sales rose 4.5% to over 163 billion yen from 156 billion yen in the prior year.</p><p>For the fiscal year ending Feb. 28, 2027, the company does not provide an earnings forecast due to its scheduled delisting on May 11.</p><p>Hisamitsu Pharmaceutical plans to pay no dividends for the current fiscal year, which is lower than the 90 yen per share paid in the year-ago period.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"YCL","symbol_name":"ProShares Ultra Yen","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2627433070","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2627433070","pubTimestamp":1776070050,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hisamitsu Pharmaceutical's  profit attributable to owners of the parent fell 12% to 19.2 billion yen for the fiscal year ended Feb. 28 from 21.8 billion yen a year earlier.The pharmaceutical group's earnings per share declined to 268.22 yen from 295.15 yen a year ago, according to a Tokyo bourse filing on Monday.Net sales rose 4.5% to over 163 billion yen from 156 billion yen in the prior year.For the fiscal year ending Feb. 28, 2027, the company does not provide an earnings forecast due to its scheduled delisting on May 11.Hisamitsu Pharmaceutical plans to pay no dividends for the current fiscal year, which is lower than the 90 yen per share paid in the year-ago period.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"YCL":"ProShares Ultra Yen","HEWJ":"日本ETF汇率对冲-iShares","FXY":"日元ETF-CurrencyShares","YCS":"日元ETF-ProShares两倍做空"},"translate_title":"久光制药全年利润下降12%","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HEWJ":0.9,"FXY":0.9,"YCL":0.9,"YCS":0.9},"content_text":"Hisamitsu Pharmaceutical's (TYO:4530) profit attributable to owners of the parent fell 12% to 19.2 billion yen for the fiscal year ended Feb. 28 from 21.8 billion yen a year earlier.The pharmaceutical group's earnings per share declined to 268.22 yen from 295.15 yen a year ago, according to a Tokyo bourse filing on Monday.Net sales rose 4.5% to over 163 billion yen from 156 billion yen in the prior year.For the fiscal year ending Feb. 28, 2027, the company does not provide an earnings forecast due to its scheduled delisting on May 11.Hisamitsu Pharmaceutical plans to pay no dividends for the current fiscal year, which is lower than the 90 yen per share paid in the year-ago period.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2627433070","isCrawlerRequest":true}